# A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

> **NCT04622293** · PHASE4 · COMPLETED · sponsor: **Rochester Center for Behavioral Medicine** · enrollment: 44 (actual)

## Conditions studied

- Chronic Fatigue Syndrome
- Myalgic Encephalomyelitis

## Interventions

- **DRUG:** Solriamfetol Oral Tablet [Sunosi]
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04622293
- **Lead sponsor:** Rochester Center for Behavioral Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-27
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04622293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04622293, "A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04622293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*